Nuveen Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-589,525
| Closed | -$40.1M | – | 3232 |
|
|
2022
Q3 | $40.1M | Sell |
589,525
-60,744
| -9% | -$4.14M | 0.02% | 619 |
|
|
2022
Q2 | $20.8M | Buy |
650,269
+367,895
| +130% | +$11.8M | 0.01% | 1023 |
|
|
2022
Q1 | $9.08M | Buy |
282,374
+1,510
| +0.5% | +$48.5K | ﹤0.01% | 1709 |
|
|
2021
Q4 | $7.44M | Buy |
280,864
+83,125
| +42% | +$2.2M | ﹤0.01% | 1864 |
|
|
2021
Q3 | $5.54M | Sell |
197,739
-174,174
| -47% | -$4.88M | ﹤0.01% | 2144 |
|
|
2021
Q2 | $13M | Sell |
371,913
-180,921
| -33% | -$6.34M | ﹤0.01% | 1685 |
|
|
2021
Q1 | $22.5M | Sell |
552,834
-136,664
| -20% | -$5.57M | 0.01% | 1230 |
|
|
2020
Q4 | $29.9M | Buy |
689,498
+309,289
| +81% | +$13.4M | 0.01% | 976 |
|
|
2020
Q3 | $21M | Buy |
380,209
+182,224
| +92% | +$10M | 0.01% | 1031 |
|
|
2020
Q2 | $12.5M | Sell |
197,985
-78,377
| -28% | -$4.95M | 0.01% | 1335 |
|
|
2020
Q1 | $14.1M | Buy |
276,362
+18,077
| +7% | +$924K | 0.01% | 1090 |
|
|
2019
Q4 | $20.5M | Sell |
258,285
-237,320
| -48% | -$18.9M | 0.01% | 1148 |
|
|
2019
Q3 | $24M | Buy |
495,605
+276,402
| +126% | +$13.4M | 0.01% | 1035 |
|
|
2019
Q2 | $11.5M | Buy |
+219,203
| New | +$11.5M | ﹤0.01% | 1510 |
|